112. Treatment Dilemmas In Immunocompromised Hosts
Saturday, October 23, 2010: 10:30 AM-12:00 PM
East Ballroom ABC

Learning Objectives:

This program is directed to infectious disease clinicians, microbiologists, clinical researchers, and other health care workers, both in training and those who have completed training, interested in the care of transplant recipients.  Upon completion of this symposium, the participant will be able to:

  • review management options for febrile neutropenic patients at risk for multi-drug resistant infections
  • recognize and manage immune reconstitution syndrome in transplant recipients
  • understand treatment options for tuberculosis post solid organ transplantation

Target Audience: Scientists, Researchers, Pharmacists, Nurses, Microbiologists, Investigators, Infectious Disease Physicians, Infectious Disease Pediatricians, Infection Preventionists, Hospital Epidemiologists, Health Care Workers, Fellows-in-Training/Fellows, Clinicians, Academicians

Topical Category: O. Transplant infectious diseases

Tracks: Adult ID

CME Credits: CME Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE Maximum of 1.5 hours of Pharmacy CE credit possible

ACPE Number: 0245-9999-10-074-L01-P (Knowledge)

Moderators:  Aimee Zaas, MD, MHS, Duke University and Robert Read, MD, FIDSA, University of Sheffield


A. Zaas, Yes
Covance: Scientific Advisor, Consulting fee
Pfizer (spouse): Speaker's Bureau and spouse on speakers bureau, Speaker honorarium
Pfizer: Grant Investigator, Grant recipient

R. Read, Yes
Bayer Schering, Inc.: Consultant, Consulting fee
Interleukin Genetics: Consultant, Consulting fee
Astellas: Consultant, Consulting fee
Novartis: Grant Investigator, Research support

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 21 with the exception of research findings presented at IDSA press conferences.


Copyright IDSA 2009 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209